HRTX Heron Therapeutics, Inc.

$0.32▼ -2.11% Healthcare Other
After hours $0.32▲ +2.00% Sep 11, 7:30 PM ET
Volume 1.37M Avg Volume (10D) 1.61M
Key Metrics & Fundamentals
Market Cap
$59.90M
P/E Ratio
–
Div Yield
–%
52W Range
0.30 - 1.58
% vs 50 MA
-20.75%
% vs 200 MA
-63.74%
RSI-14
38.4
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.76
Free Cash Flow
-$2.35M
Gross Rev
$37.67M
Gross Profit
$26.09M
EBITDA
-$1.59M
COGS
$11.57M
Operating Exp
$28.14M
Operating Income
-$2.04M
EBIT
-$2.04M
Pretax Income
-$5.49M
Net Income
-$5.49M
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
--HC Wainwright Downgrades Heron Therapeutics to Neutral From Buy
MT Newswires · Aug 11, 2026 11:30 AM
Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ...
GuruFocus.com · Aug 10, 2026 9:01 PM
Heron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook
InvestorsHub · Aug 10, 2026 3:05 PM
Heron Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 10, 2026 2:04 PM
Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 10, 2026 1:10 PM
Heron Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 12:06 PM
BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates
Zacks · Aug 5, 2026 1:00 PM
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
GlobeNewswire · Jul 27, 2026 12:30 PM
New Strong Sell Stocks for July 15th
Zacks · Jul 15, 2026 10:24 AM
Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision
Simply Wall St. · Jul 12, 2026 12:16 AM
Financial Overview - Income Statement Quarterly

See HRTX's money flow as a full page

Social Sentiment
Avg +0.40 · 2 posts
TradeDiscussionStuck in the mud
r/options · Sep 25, 2024
The author expresses regret and inability to exit the trade, indicating a negative situation.
negative +0.10
DiscussionTradeLong Term Hold Growth Stock and Stock Explosion - HRTX / NDRA
r/investing · Jun 3, 2024
Users are discussing accumulating HRTX and NDRA, indicating positive sentiment.
positive +0.70
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙